NOTE 14 - SUBSEQUENT EVENTS (Details) - Chief Operating Officer [Member] - USD ($) |
Aug. 01, 2015 |
Oct. 01, 2014 |
|---|---|---|
| NOTE 14 - SUBSEQUENT EVENTS (Details) [Line Items] | ||
| Officers' Compensation | $ 150,000 | |
| Share-based Compensation Arrangement by Share-based Payment Award, Description | annual stock options, exercisable at the fair market value of CLS Labs' common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million | |
| Deferred Compensation Arrangement with Individual, Description | entitled to receive a performance bonus equal to 2% of CLS Labs’ annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary) | |
| Subsequent Event [Member] | ||
| NOTE 14 - SUBSEQUENT EVENTS (Details) [Line Items] | ||
| Officers' Compensation | $ 150,000 | |
| Share-based Compensation Arrangement by Share-based Payment Award, Description | annual stock options, exercisable at the fair market value of the Company’s common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million | |
| Deferred Compensation Arrangement with Individual, Description | he is entitled to receive a performance bonus equal to 2% of the Company’s annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary) | |
| Restricted Stock [Member] | ||
| NOTE 14 - SUBSEQUENT EVENTS (Details) [Line Items] | ||
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | 250,000 | |
| Restricted Stock [Member] | Subsequent Event [Member] | ||
| NOTE 14 - SUBSEQUENT EVENTS (Details) [Line Items] | ||
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | 250,000 | |
| Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 1 year |